Roland Knoblauch

Person

Doylestown, PA, US

People

Patents Applicationslast 30 patents

Information Patent Application
Dosing Regimen for Therapies Comprising Bispecific Anti-EGFR/C-Met...
- Publication number 20240109969
- Publication date Apr 4, 2024
- JANSSEN BIOTECH, INC.
- Roland Knoblauch
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
High Concentration Bispecific Antibody Formulations
- Publication number 20240034813
- Publication date Feb 1, 2024
- JANSSEN BIOTECH, INC.
- Roland Knoblauch
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Use of Amivantamab to Treat Colorectal Cancer
- Publication number 20230183360
- Publication date Jun 15, 2023
- JANSSEN BIOTECH, INC.
- Roland Knoblauch
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Use of Approved Bispecific EGFR and Met Specific Antibody Drug Prod...
- Publication number 20230174677
- Publication date Jun 8, 2023
- JANSSEN BIOTECH, INC.
- Roland Knoblauch
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
High Concentration Bispecific Antibody Formulations
- Publication number 20220395573
- Publication date Dec 15, 2022
- JANSSEN BIOTECH, INC.
- Roland Knoblauch
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Treatment of Non-Small Cell Lung Cancer with EGFR Mutations
- Publication number 20220064306
- Publication date Mar 3, 2022
- JANSSEN BIOTECH, INC.
- Roland Knoblauch
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Treatment of Patients Having c-Met Exon 14 Skipping Mutations
- Publication number 20210253717
- Publication date Aug 19, 2021
- JANSSEN BIOTECH, INC.
- Roland Knoblauch
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Roland Knoblauch

Person

Patents Applicationslast 30 patents

Dosing Regimen for Therapies Comprising Bispecific Anti-EGFR/C-Met...

High Concentration Bispecific Antibody Formulations

Use of Amivantamab to Treat Colorectal Cancer

Use of Approved Bispecific EGFR and Met Specific Antibody Drug Prod...

High Concentration Bispecific Antibody Formulations

Treatment of Non-Small Cell Lung Cancer with EGFR Mutations

Treatment of Patients Having c-Met Exon 14 Skipping Mutations